Paediatric pulmonary drug delivery: considerations in asthma treatment

Bibliography

• AMERICAN ACADEMY OF ALLERGY ASTHMA AND IMMUNOLOGY (AAAAI): Pediatric Asthma: Promoting Best Practice in Children. (2004):88–90.
   Google Scholar
• ••US guidelines focusing on themanagement of asthma in children.
   Google Scholar
• NEWHOUSE MT: Principles of aerosol therapy. Chest (1982) 1:39S–41S.
   Google Scholar
• FOUCARD T: Aggressive treatment of childhood asthma with local steroids. Good or bad? Allergy (1996) 51:367–371.
   Google Scholar
• THORSSON L, EDSBACKER S: Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer. Eur. Respir J. (1998) 12:1340–1345.
   Google Scholar
• EVERARD ML, DEVADASON SG, SUMMERS QA, LESOUEF PN: Factors affecting total and 'respirable' dose delivered by a salbutamol metered dose inhaler. Thorax (1995) 50:746–749.
   Google Scholar
• CROMPTON GK: Problems patients have using pressurized aerosol inhalers. Eur. Respir Dis. Suppl. (1982) 63:101–104.
   Google Scholar
• BLAQUIERE P, CHRISTENSEN DB, CARTER WB, MARTIN TR: Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am. Rev Respir. Dis. (1989) 140:910–916.
   Google Scholar
• KAMPS AW, VAN EWIJK B, ROORDA RJ, BRAND PL: Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr. Pulmonol (2000) 29:39–42.
   Google Scholar
• EVERARD ML: Role of inhaler competence and contrivance in 'difficult asthma'. Paediatr. Respir. Rev (2003) 4:135–142.
   Google Scholar
• FOR ASTHMA:Global Strategy for Asthma Management and Prevention. Updated (2003) NIH Publication No. 02–3659.
   Google Scholar
• ••International guidelines describing the treatment and prevention of asthma.
   Google Scholar
• RAM FS, WRIGHT J, BROCKLEBANK D, WHITE JE ON BEHALF OF THE NATIONAL HEALTH TECHNOLOGY ASSESSMENT REVIEW GROUP: Systematic review of clinical effectiveness of pressurised metered-dose inhalers versus other hand held inhaler devices for delivering 132 agonists bronchodilators in asthma. Br. Med. J. (2001) 323: 1–7.
   Google Scholar
• DOLOVICH MB, AHRENS RC, HESS DR et al.: Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest (2005) 127:335–371.
   Google Scholar
• ••Systematic review with evidence-based guidelines on aerosol therapy of bronchodilators and glucocorticosteroids based on randomised controlled studies of adults or children in outpatient and inpatient settings.
   Google Scholar
• CALLAGHAN C, WRIGHT P: In: Drug Delivery to the Lung. Bisgaard H, O'Callaghan C, Smaldone GC (Eds), Marcel Dekker, New York, NY, USA (2001) 162:337–370.
   Google Scholar
• BARRY PW, O'CALLAGHAN C: The influence of inhaler selection on efficacy of asthma therapies. Adv. Drug Deily Rev (2003) 55:879–923.
   Google Scholar
• •Detailed review that describes the relationship betweeen in vitro characteristics of devices, lung deposition and clinical efficacy, and summarises published data comparing the clinical efficacy of various devices.
   Google Scholar
• GANDERTON D: General factors influencing drug delivery to the lung. Respir Med. (1997) 91:13–16.
   Google Scholar
• EVERARD ML: Inhalation therapy for infants. Adv. Drug Del. Rev. (2003) 55:869–878.
   Google Scholar
• •Review of anatomical, behavioural, physiological and device-specific considerations that influence the delivery of aerosol therapy to infants.
   Google Scholar
• THORSSON L, GELLER D: Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable and COPD: focus on budesonide. Respir Med. (2005) 99:836–849.
   Google Scholar
• DOLOVICH MA, MACINTYRE NR: Consensus conference on aerosols and delivery devices. Consensus statement. Aerosols and delivery devices. Respir. Care (2000) 45:589–596.
   Google Scholar
• CLARK AR: The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int. J. Pharm. (1995) 115:69–78.
   Google Scholar
• RUBIN BK, FINK JB: The delivery of inhaled medication to the young child. Pediatr. Clin. N Am. (2003) 50:717–731.
   Google Scholar
• BISGAARD H, ANHOJ J, WILDHABER JH. In: Drug Delivery to the Lung. Bisgaard H, O'Callaghan C, Smaldone GC (Eds), Marcel Dekker, New York, NY, USA (2001) 162:389–420.
   Google Scholar
• FINK JB: Aerosol delivery to ventilated infant and pediatric patients. Respir. Care (2004) 49:653–665.
   Google Scholar
• •Review of factors to consider when choosing aerosol therapy for infants; summarises lung deposition data from studies of nebulised aerosol therapy in infants and children.
   Google Scholar
• COLE CH: Special problems in aerosol delivery: neonatal and pediatric considerations. Respir Care. (2000) 45:646–651.
   Google Scholar
• BENEDICTIS FM, SELVAGGIO D: Use of inhaler devices in pediatric asthma. Pediatr. Drugs (2003) 5:629–638.
   Google Scholar
• GELLER DE: Choosing a nebulizer for cystic fibrosis applications. Curr. Opin. Pulm. Med. (1997) 3:414–419.
   Google Scholar
• •Review of salient factors to consider when choosing a nebuliser device.
   Google Scholar
• DHAND R: New frontiers in aerosol delivery during mechanical ventilation. Respir. Care (2004) 49:666–677.
   Google Scholar
• NEWMAN SP, PELLOW PG, CLAY MM, CLARKE SW: Evaluation of jet nebulisers for use with gentamicin solution. Thorax (1985) 40:671–676.
   Google Scholar
• DOHERTY M, THOMAS S, PAGE C, BRADBEER C, NUNAN T, BATEMAN N: Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill. Thorax (1990) 45:460–464.
   Google Scholar
• BUSH A: Asthma in the child under five. Br. J. Hosp. Med. (1996) 55:110–114.
   Google Scholar
• NATIONAL ASTHMA EDUCATION AND PREVENTION PROGRAM (NATIONAL HEART, AND BLOOD INSTITUTE): Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. NIH publication No. 97–4051 (July 1997).
   Google Scholar
• CALLAGHAN C, BARRY PW: The science of nebulized drug delivery. Thorax (1997) 52 (Supp1.2) : S31–544.
   Google Scholar
• EVERARD ML, CLARK AR, MILNER AD: Drug delivery from jet nebulisers. Arch. Dis. Child. (1992) 67: 586–591.
   Google Scholar
• SMALDONE GC, CRUZ-RIVERA M, NIKANDER K: In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J.Aerosol. Med. (1998) 11:113–125.
   Google Scholar
• LOFFERT DT, IKLE D, NELSON HS: A comparison of commercial jet nebulizers. Chest (1994) 106:1788–1793.
   Google Scholar
• ILES R, LISTER P, EDMUNDS AT: Crying significantly reduces absorption of aerosolised drug in infants. Arch. Dis. Child. (1999) 81:163–165.
   Google Scholar
• AMIRAV I, NEWHOUSE MT: Aerosol therapy with valved holding chambers in young children: importance of the face mask seal. Pediatrics (2001) 108: 389–394.
   Google Scholar
• MURAKAMI G, IGARASHI T, ADACHI Y et al.: Measurement of bronchial hyperactivity in infants and preschool children using a new method. Ann. Allergy (1990) 64:383–387.
   Google Scholar
• GELLER DE, KESSER KC, TIDDENS HA: Delivery of budesonide inhalation suspension (BIS) through an infant upper airway model. Poster presented at: 99th International Conference of the American Thoracic Society. Seattle, WA, USA (2003)
   Google Scholar
• RUBIN BK, FINK JB: Aerosol therapy forchildren. Respir. Care Clin. N Am. (2001) 7:175–213.
   Google Scholar
• AGERTOFT L, ANDERSEN A, WEIBULL E, PEDERSEN S: Systemic availability and pharmacokinetics of nebulised budesonide in preschool children. Arch. Dis. Child. (1999a) 80:241–247.
   Google Scholar
• CHUA HL, COLLIS GG, NEWBURY AM et al: The influence of age on aerosol deposition in children with cystic fibrosis. Eur. Respir J. (1994) 7:2185–2191.
   Google Scholar
• EVERARD ML, HARDY JG, MILNER AD: Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. Thorax (1993) 48:1045–1046.
   Google Scholar
• MELLON M, LEFLEIN J, WALTON-BOWEN K, CRUZ-RIVERA M, FITZPATRICK S, SMITH JA: Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am. J. Respir. Grit. Care Med. (2000) 162:593–598.
   Google Scholar
• DONOHUE WJ THE NATIONAL ASSOCIATION FOR MEDICAL DIRECTION OF RESPIRATORY CONSENSUS GROUP: Guidelines for the use of nebulizers in the home and at domiciliary sites. Chest (1996) 109:814–820.
   Google Scholar
• JANSSENS HM, KRIJGSMAN A, VERBRAAK TF, HOP WC, JONGSTE JC, TIDDENS HA: Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. I. Aerosol Med. (2004) 17:51–61.
   Google Scholar
• KAMPS AW, BRAND PL, ROORDA RJ: Determinants of correct inhalation technique in children attending a hospital-based asthma clinic. Acta Paediatr. (2002) 91:159–163.
   Google Scholar
• WILDHABER JH, DEVADASON SG, EBER E et al: Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax (1996) 51:985–988.
   Google Scholar
• BARRY PW, O'CALLAGHAN C: Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Eur. Respir J. (1994) 7:1707–1709.
   Google Scholar
• RAU JL, RESTREPO RD, DESHPANDE V: Inhalation of single versus multiple metered-dose bronchodilator actuations from reservoir devices. An in vitro study. Chest (1996) 109:969–974.
   Google Scholar
• BARRY PW, O'CALLAGHAN C: A comparative analysis of the particle size output of beclomethasone dipropionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and AeroChamber spacer devices. BE J. Clin. Pharmacol (1999) 47:357–360.
   Google Scholar
• JANSSENS HM, VAN WIEL EC, VERBRAAK AF, JONGSTE JC, MERKUS PJ, TIDDENS HA: Aerosol therapy and the fighting toddler: is administration during sleep an alternative?" Aerosol Med. (2003) 16:395–400.
   Google Scholar
• DUBUS J-C, ANHOJ J: Inhaled steroid delivery from small-volume holding chambers depends on age, holding chamber, and interface in children. ./. Aerosol Med. (2004) 17:225–230.
   Google Scholar
• TAL A, GOLAN H, GRAUER N, AVIRAM M, ALBIN D, QUASTEL MR: Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. Pediatr. (1996) 128:479–484.
   Google Scholar
• BORGSTROM L, BISGAARD H, O'CALLAGHAN C, PEDERSEN S. In: Drug Delivery to the Lung. Bisgaard H, O'Callaghan C, Smaldone GC (Eds), Marcel Dekker, New York, NY, USA (2001) 162:421–448.
   Google Scholar
• BISGAARD H, KLUG B, SUMBY BS, BURNELL PK: Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma. Eur. Respir. 1 (1998) 11:1111–1115.
   Google Scholar
• AGERTOFT L, PEDERSEN S: Importance of training for correct Turbuhaler use in preschool children. Acta Paediatr. (1998) 87:842–847.
   Google Scholar
• NIELSEN KG, AUK IL, BOJSEN K, IFVERSEN M, KLUG B, BISGAARD H: Clinical effect of DiskusTm dry powder inhaler and low and high inspiratory flow-rates in asthmatic children. Eur. Respir. (1998) 11:350–354.
   Google Scholar
• AGERTOFT L, PEDERSEN S, NIKANDER K: Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma." Aerosol. Med. (1999b) 12:161–169.
   Google Scholar
• PEDERSEN S: How to use a rotahaler. Arch. Dis. Child. (1986) 61:11–14.
   Google Scholar
• PEDERSEN S, HANSEN OR, FUGLSANG G: Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch. Dis. Child (1990) 65: 308–310.
   Google Scholar
• OLSSON B: Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers?" Aerosol. Med. (1995) 8\(Suppl. 3):S13–S19.
   Google Scholar
• AGERTOFT L, PEDERSEN S: Lung deposition and systemic availability of fluticasone diskus and budesonide Turbuhaler in children. Am. I Respir: Grit. Care Med. (2003) 168:779–782.
   Google Scholar
• WILDHABER JH, DEVADASON SG, HAYDEN MJ, EBER E, SUMMERS QA, LESOM PN: Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers. Pediatr. Pulmonol (1997) 23:212–216.
   Google Scholar
• WILDHABER JH, DORE ND, WILSON JM, DEVADASON SG, LESOM PN: Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? LI vivo comparison of lung deposition in children. Pediatr. (1999) 135:28–33.
   Google Scholar
• HIRST PH, BACON RE, PITCAIRN GR, SILVASTI M, NEWMAN SP: A comparison of the lung deposition of budesonide from Easyhaler®, Turbuhaler® and pMDI plus spacer in asthmatic patients. Respir: Med. (2001) 95:720–727.
   Google Scholar
• HIRST PH, NEWMAN SP, CLARK DA, HERTOG MG: Lung deposition of budesonide from the novel dry powder inhaler Airmax". Respir: Med. (2002) 96:389–396.
   Google Scholar
• HIRSCH T, PETER-KERN M, KOCH R et al.: Influence of inspiratory capacity on bronchodilatation via Turbuhaler or pressurized metered-dose inhaler in asthmatic children: a comparison. Respir: Med. (1997) 91:341–346.
   Google Scholar
• SVENONIUS E, ARBORELIUS M, WIBERG R, STAHL E, SVENSSON M: A comparison of terbutaline inhaled by Turbuhaler and by a chlorofluorocarbon (CPC) inhaler in children with exercise- induced asthma. Allergy (1994) 49:408–412.
   Google Scholar
• CHAMBERS S, DUNBAR J, TAYLOR B: Inhaled powder compared with aerosol administration of fenoterol in asthmatic children. Arch. Dis. Child (1980) 55:73–74.
   Google Scholar
• REISER J, FRAME MH, WARNER JO: The potential value of a 750-ml spacer for the administration of inhaled corticosteroids to children. Pediatric Pulmonol (1986) 2:237–243.
   Google Scholar
• BROCKLEBANK D, WRIGHT J, CATES C ON BEHALF OF THE NATIONAL HEALTH TECHNOLOGY ASSESSMENT REVIEW GROUP: Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. Br. Med. J. (2001) 323:1–7.
   Google Scholar
• AGERTOFT L, PEDERSEN S: A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. I Allergy Clin. Immunol (1997) 99:773–780.
   Google Scholar
• AGERTOFT L, PEDERSEN S: Importance of the inhalation device on the effect of budesonide. Arch. Dis. Child. (1993) 69:130–133.
   Google Scholar
• KEMP JP, SKONER DP, SZEFLER SJ, WALTON-BOWEN K, CRUZ-RIVERA M, SMITH JA: Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann. Allergy Asthma Immunol (1999) 83:231–239.
   Google Scholar
• BAKER JW, MELLON M, WALD J, WELCH M, CRUZ-RIVERA M, WALTON-BOWEN K: A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics (1999) 103:414–421.
   Google Scholar
• SHAPIRO G, MENDELSON L, KRAEMER MJ, CRUZ-RIVERA M, WALTON-BOWEN K, SMITH JA: Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. I Allergy Clin. Immunol. (1998) 102:789–796.
   Google Scholar
• LEFLEIN JG, SZEFLER SJ, MURPHY KR et al: Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics (2002) 109:866–872.
   Google Scholar
• VOLOVITZ B, SOFERMAN R, BLAU H, NUSSINOVITCH M, VARSANO I: Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. Allergy Clin. Immunol (1998) 101:464–469.
   Google Scholar
• BERGER WE, SHAPIRO GG: The use ofinhaled corticosteroids for persistent asthma in infants and young children. Ann. Allergy Asthma Immunol (2004) 92:387–400.
   Google Scholar
• ROORDA RJ, MEZEI G, BISGAARD H, MADEN C: Response of preschool children with asthma symptoms to fluticasone propionate. J. Allergy Clin. Immunol (2001) 108:540–546.
   Google Scholar
• CHAVASSE RJ, BASTIAN-LEE Y, RICHTER H, HILLIARD T, SEDDON P: Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone. Arch. Dis. Child. (2001) 85:143–148.
   Google Scholar
• PRICE JF, WELLER PH: Comparison of fluticasone proprionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Respir: Med. (1995) 89:363–368.
   Google Scholar
• HOEKX JC, HEDLIN G, PEDERSEN W, SORVA R, HOLLINGWORTH K, EFTHIMIOU J: Fluticasone propionate compared with budesonide: double-blind trial in asthmatic children using powder devices at a dosage of 400 pg-day 1. Eur. Respir: J. (1996) 9:2263–2272.
   Google Scholar
• FERGUSON AC, SPIER S, MANJRA A, VERSTEEGH F, MARK S, ZHANG P: Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. Pediatr. (1999) 134:422–427.
   Google Scholar
• PEARLMAN DS, RUFF ME et al.: Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann. Allergy Asthma Immunol (2000) 85:407–415.
   Google Scholar
• PEDEN DB, BERGER WE, NOONAN MJ et al.: Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. I Allergy Clin. Immunol (1998) 102:32–38.
   Google Scholar
• KATZ Y, LEBAS FX, MEDLEY HV, ROBSON R: Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Chn. Ther. (1998) 20:424–437.
   Google Scholar
• SHAPIRO G, BRONSKY EA, LAFORCE CF et al: Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Pediatr (1998) 132:976–982.
   Google Scholar
• JONASSON G, CARLSEN K- BLOMQVIST P: Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. Eur. Respir: (1998) 12:1099–1104.
   Google Scholar
• TIDDENS H: Matching the device to the patient. Pediatr: Puhnonol. (2004) 26:26–29.
   Google Scholar
• FAIRFAX A, HALL I, SPELMAN R: A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate. Ann. Allergy Asthma Irrununol. (2001) 86:575–582.
   Google Scholar
• EDERLE K, STUDY GROUP: Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study. Eur. Rev Med. Pharmacol. Sci. (2003) 7:45–55.
   Google Scholar
• LENNEY J, INNES JA, CROMPTON GK: Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir: Med. (2000) 94:496–500.
   Google Scholar